» Articles » PMID: 20052289

Interferon-inducible IFI16, a Negative Regulator of Cell Growth, Down-regulates Expression of Human Telomerase Reverse Transcriptase (hTERT) Gene

Overview
Journal PLoS One
Date 2010 Jan 7
PMID 20052289
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Increased levels of interferon (IFN)-inducible IFI16 protein (encoded by the IFI16 gene located at 1q22) in human normal prostate epithelial cells and diploid fibroblasts (HDFs) are associated with the onset of cellular senescence. However, the molecular mechanisms by which the IFI16 protein contributes to cellular senescence-associated cell growth arrest remain to be elucidated. Here, we report that increased levels of IFI16 protein in normal HDFs and in HeLa cells negatively regulate the expression of human telomerase reverse transcriptase (hTERT) gene.

Methodology/principal Findings: We optimized conditions for real-time PCR, immunoblotting, and telomere repeat amplification protocol (TRAP) assays to detect relatively low levels of hTERT mRNA, protein, and telomerase activity that are found in HDFs. Using the optimized conditions, we report that treatment of HDFs with inhibitors of cell cycle progression, such as aphidicolin or CGK1026, which resulted in reduced steady-state levels of IFI16 mRNA and protein, was associated with increases in hTERT mRNA and protein levels and telomerase activity. In contrast, knockdown of IFI16 expression in cells increased the expression of c-Myc, a positive regulator of hTERT expression. Additionally, over-expression of IFI16 protein in cells inhibited the c-Myc-mediated stimulation of the activity of hTERT-luc-reporter and reduced the steady-state levels of c-Myc and hTERT.

Conclusions/significance: These data demonstrated that increased levels of IFI16 protein in HDFs down-regulate the expression of hTERT gene. Our observations will serve basis to understand how increased cellular levels of the IFI16 protein may contribute to certain aging-dependent diseases.

Citing Articles

Regulation of cellular senescence by innate immunity.

Hou J, Zheng Y, Gao C Biophys Rep. 2024; 9(6):338-351.

PMID: 38524701 PMC: 10960571. DOI: 10.52601/bpr.2023.230032.


Telomerase Expression Related with Poor Immune Response to HCV Core Antigen in Egyptian HCV Patients' PBMCs.

Ibrahim I, Ali O, El-Sahar A, Elrefaei M, El-Sheikh N J Clin Exp Hepatol. 2023; 13(6):1008-1016.

PMID: 37975051 PMC: 10643511. DOI: 10.1016/j.jceh.2023.06.004.


Comprehensive analysis identifies IFI16 as a novel signature associated with overall survival and immune infiltration of skin cutaneous melanoma.

Wang H, Xie X, Zhu J, Qi S, Xie J Cancer Cell Int. 2021; 21(1):694.

PMID: 34930258 PMC: 8690488. DOI: 10.1186/s12935-021-02409-6.


Increased expression of IFI16 predicts adverse prognosis in multiple myeloma.

Huang W, Qian T, Huang Z, Liu Y, Cui L, Zhu P Pharmacogenomics J. 2021; 21(4):520-532.

PMID: 33712724 DOI: 10.1038/s41397-021-00230-y.


Type I interferons and related pathways in cell senescence.

Frisch S, MacFawn I Aging Cell. 2020; 19(10):e13234.

PMID: 32918364 PMC: 7576263. DOI: 10.1111/acel.13234.


References
1.
Katayama T, Nakanishi K, Nishihara H, Kamiyama N, Nakagawa T, Kamiyama T . Type I interferon prolongs cell cycle progression via p21WAF1/CIP1 induction in human colon cancer cells. Int J Oncol. 2007; 31(3):613-20. View

2.
Akiyama M, Iwase S, Horiguchi-Yamada J, Saito S, Furukawa Y, Yamada O . Interferon-alpha repressed telomerase along with G1-accumulation of Daudi cells. Cancer Lett. 1999; 142(1):23-30. DOI: 10.1016/s0304-3835(99)00109-3. View

3.
Borden E, Lindner D, Dreicer R, Hussein M, Peereboom D . Second-generation interferons for cancer: clinical targets. Semin Cancer Biol. 2000; 10(2):125-44. DOI: 10.1006/scbi.2000.0315. View

4.
Niewold T, Hua J, Lehman T, Harley J, Crow M . High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun. 2007; 8(6):492-502. PMC: 2702174. DOI: 10.1038/sj.gene.6364408. View

5.
Chin L, Artandi S, Shen Q, Tam A, Lee S, Gottlieb G . p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell. 1999; 97(4):527-38. DOI: 10.1016/s0092-8674(00)80762-x. View